$297.05 +0.60 (%) Actavis PLC - NYSE

Apr. 17, 2015 | 04:00 PM

Partner Headlines

  1. Global Worries Sink U.S. Stocks; Apple Breaches Support Level

    IBD | Apr. 17, 2015 | 16:37PM EST
  2. How To Buy A Rising Market Leader On A Pullback

    IBD | Apr. 14, 2015 | 17:03PM EST
  3. Andreas Halvorsen Keeps Buying DVA, HLT, ACT

    GuruFocus | Apr. 10, 2015 | 22:26PM EST
  4. Actavis contraceptive OK'd

    IBD | Feb. 27, 2015 | 18:50PM EST
  5. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 27, 2015 | 16:27PM EST
  6. Meet IBD's 4 A Stocks With Rising Earnings Estimates

    IBD | Feb. 26, 2015 | 19:47PM EST
  7. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  8. Stock Chart Skills: The Beauty Of A Symmetrical Base

    IBD | Feb. 24, 2015 | 17:22PM EST
  9. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  10. Tax System Gives Edge To Foreign Buys Of U.S. Firms

    IBD | Feb. 23, 2015 | 18:51PM EST
  11. Five Top-Rated Medical Stocks To Keep Monitoring

    IBD | Feb. 23, 2015 | 18:22PM EST
  12. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  13. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  14. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD | Feb. 22, 2015 | 17:46PM EST
  15. John Paulson's Top Buys

    GuruFocus | Feb. 21, 2015 | 22:52PM EST
  16. Boeing Lifts Dow; Nasdaq Gets Apple Boost

    IBD | Feb. 20, 2015 | 14:56PM EST
  17. Medical Stocks Rise; Valeant Said To Be Near Buy Of Salix

    IBD | Feb. 20, 2015 | 11:54AM EST
  18. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD | Feb. 20, 2015 | 11:42AM EST
  19. Stock Futures Dip, Turn Mixed; Five Market Factors For Friday

    IBD | Feb. 20, 2015 | 09:11AM EST
  20. Nasdaq Climbs Modestly As Indexes Close Mixed

    IBD | Feb. 19, 2015 | 16:13PM EST
  21. ValueWalk On What Might Be Pershing Square's 'Big Secret Short'

    Benzinga | Feb. 19, 2015 | 15:53PM EST
  22. Why Today's Stock Market Action Is Encouraging

    IBD | Feb. 19, 2015 | 11:55AM EST
  23. Actavis' Growth 'Underappreciated,' Sterne Agee Says

    Benzinga | Feb. 19, 2015 | 08:23AM EST
  24. Actavis Announces Proposed Public Offerings of Ordinary Shares and Mandatory Convertible Preferred Shares in Connection with Pending Acquisition of Allergan

    Benzinga | Feb. 19, 2015 | 07:40AM EST
  25. Actavis Tops, Changing Name

    IBD | Feb. 18, 2015 | 18:22PM EST
  26. A Look At Dan Loeb's Diversified 13F

    Benzinga | Feb. 18, 2015 | 18:04PM EST
  27. Stephen Mandel's Lone Pine Capital Loves Tech, Consumer Stocks

    Benzinga | Feb. 18, 2015 | 17:18PM EST
  28. Paulson & Company's Q4 Moves: Healthcare And Beyond

    Benzinga | Feb. 18, 2015 | 16:12PM EST
  29. Actavis Tops Views, Announces Name Change To Allergan

    IBD | Feb. 18, 2015 | 11:24AM EST
  30. UPDATE: Actavis Tops Q4 Views

    Benzinga | Feb. 18, 2015 | 07:55AM EST
  31. US Stock Futures Mostly Flat; FOMC Minutes In Focus

    Benzinga | Feb. 18, 2015 | 07:37AM EST
  32. Earnings Scheduled For February 18, 2015

    Benzinga | Feb. 18, 2015 | 05:08AM EST
  33. Jack In The Box Gets Cooking After Hours

    IBD | Feb. 17, 2015 | 16:55PM EST
  34. Stocks Turn Positive; Apple Marks New High

    IBD | Feb. 17, 2015 | 13:34PM EST
  35. Actavis Leads IBD 50 Stocks With Earnings This Week

    IBD | Feb. 14, 2015 | 08:02AM EST
  36. Salix, Top Drug Stocks Rally As Merger Mania Heats Up

    IBD | Feb. 13, 2015 | 18:08PM EST
  37. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  38. AstraZeneca's Q4 Misses Profit Estimates, But Management Stays Upbeat

    GuruFocus | Feb. 13, 2015 | 12:29PM EST
  39. Sterne Agee Dives Deep Into 3 Biotechs

    Benzinga | Feb. 13, 2015 | 10:49AM EST
  40. Actavis To Divest Pharmatect To TPG, No Terms Disclosed

    Benzinga | Feb. 13, 2015 | 08:33AM EST
  41. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD | Feb. 9, 2015 | 16:53PM EST
  42. When Stock Breakouts Don't Act Like Breakouts

    IBD | Feb. 9, 2015 | 14:57PM EST
  43. Citi On The Impact Of Biosimilars And Losing $360 Billion In Revenues

    Benzinga | Feb. 9, 2015 | 11:13AM EST
  44. Three Reasons To Let Akorn Fall Into Your Portfolio

    IBD | Feb. 6, 2015 | 11:11AM EST
  45. Pfizer Buying Hospira To Inject Growth Into Generics

    IBD | Feb. 5, 2015 | 17:27PM EST
  46. Stocks Add To Gains; Prestige Brands Surges

    IBD | Feb. 5, 2015 | 12:06PM EST
  47. Pfizer Buying Hospira To Inject Growth Into Generics

    IBD | Feb. 5, 2015 | 11:34AM EST
  48. US Stock Futures Surge Ahead Of Jobless Claims Data

    Benzinga | Feb. 5, 2015 | 07:26AM EST
  49. Top Performing Funds Favor Leisure, Medical, REITs

    IBD | Feb. 3, 2015 | 18:22PM EST
  50. Akron, Actavis Near Buy Points Amid Market Turbulence

    IBD | Feb. 3, 2015 | 17:11PM EST
Trading Center